日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial

手术可切除的促纤维增生性黑色素瘤新辅助PD-1阻断治疗:SWOG S1512 II期试验的A组队列

Kendra, Kari L; Bellasea, Shay L; Eroglu, Zeynep; Hu-Lieskovan, Siwen; Campbell, Katie M; Carson, William E 3rd; Wada, David A; Plaza, Jose A; In, Gino K; Ikeguchi, Alexandra; Hyngstrom, John; Brohl, Andrew S; Chmielowski, Bartosz; Khushalani, Nikhil I; Markowitz, Joseph; Monroe, Marcus; Contreras, Carlo M; Bowles, Tawnya; Norman, Kurt; Medina, Egmidio; Gonzalez, Cynthia R; Baselga-Carretero, Ignacio; Garcilazo, Ivan Perez; Vega-Crespo, Agustin; Chen, Jia Ming; Deen, Nataly Naser Al; Patel, Sapna P; Grossmann, Kenneth F; Sondak, Vernon K; Sharon, Elad; Moon, James; Wu, Michael C; Ribas, Antoni

Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer.

连续的转录波和 NF-κB 驱动的染色质重塑直接导致药物诱导的癌症去分化。

Su Yapeng, Liu Chunmei, Lu Xiang, Chuang Hui-Yu, Li Guideng, Shao Shiqun, Kong Yan, Lee Jihoon W, Ng Rachel H, Wong Stephanie, Robert Lidia, Warden Charles, Liu Victoria, Chen Jie, Wang Zhuo, Qin Guangrong, Tang Yin, Cheng Hanjun, Ng Alphonsus H C, Chen Daniel, Peng Songming, Xue Min, Johnson Dazy, Xu Yu, Wang Jinhui, Wu Xiwei, Shmulevich Ilya, Shi Qihui, Levine Raphael, Ribas Antoni, Baltimore David, Guo Jun, Heath James R, Wei Wei

First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid Malignancies

KPT-9274(一种首创的PAK4和NAMPT双重抑制剂)在晚期实体恶性肿瘤患者中的首次人体I期研究

Razak, Albiruni; Mahipal, Amit; Diamond, Jennifer R; Ribas, Antoni; Berlin, Jordan David; Azmi, Asfar S; Mark, Tomer; Walker, Christopher J; Chai, Yi; Kashyap, Trinayan; Gudi, Girish; Naing, Aung

INNV-27. A coordinated care model for multidisciplinary meningioma treatment and research

INNV-27. 多学科脑膜瘤治疗和研究的协调护理模式

Flaherty, Lawrence E; Othus, Megan; Atkins, Michael B; Tuthill, Ralph J; Thompson, John A; Vetto, John T; Haluska, Frank G; Pappo, Alberto S; Sosman, Jeffrey A; Redman, Bruce G; Moon, James; Ribas, Antoni; Kirkwood, John M; Sondak, Vernon K; Arum, Zora; Reddy, Megna; Morshed, Ramin A; Mirchia, Kanish; Villanueva-Meyer, Javier E; Chen, William C; Viner, Jennifer; Ward, Tracy; Huie, Charlotte; Mouton, Vaughn; Martinez, Marisol; Morrissey, Molly Rose; Bazzell, Ashley; Lewis, Stephanie; Pham, Linda; Mortezaei, Sasha; Pekmezci, Melike; Young, Jacob S; Boreta, Lauren; Susko, Matthew S; Nakamura, Jean L; Braunstein, Steve E; Levin, Marc H; Hervey-Jumper, Shawn L; Arora, Tarun; Aghi, Manish K; Perry, Arie; Sneed, Penny K; de Groot, John F; Chang, Edward F; Chang, Susan; Berger, Mitchel; McDermott, Michael W; Theodosopoulos, Philip V; Bush, Nancy Ann Oberheim; Raleigh, David R

Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials

自体细胞基因疗法中人为引入异质性:首次人体试验的战略考量

Cabanski, Christopher R; Yang, EnJun; Stewart, Mark D; Allen, Jeff D; Connolly, John E; Dugan, Ute; Greenberg, Philip D; Mackall, Crystal L; June, Carl H; Marson, Alexander; Maus, Marcela V; Ribas, Antoni

Basic rules to respond to PD-1 blockade cancer immunotherapy

应对PD-1阻断癌症免疫疗法的基本规则

Ribas, Antoni

Neoadjuvant PD-1 blockade: a new treatment option for patients with early-stage mismatch repair deficient solid tumors

新辅助PD-1阻断疗法:早期错配修复缺陷型实体瘤患者的新治疗选择

Anderson, Kristin G; Ribas, Antoni

Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer: AMBER Part 2B

PD-1 和 TIM-3 联合靶向治疗局部晚期或转移性非小细胞肺癌患者:AMBER 第二部分 B

Davar, Diwakar; Eroglu, Zeynep; Milhem, Mohammed; Becerra, Carlos; Gutierrez, Martin; Ribas, Antoni; Di Pace, Brian; Wang, Tianli; Zhang, Hailei; Ghosh, Srimoyee; Yanamandra, Niranjan; Borgovan, Theo; Srivats, Shyam; Waszak, Angela; Dhar, Arindam; LoRusso, Patricia

Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Melanoma: AMBER Cohorts 1c, 1e, and 2A

PD-1 和 TIM-3 联合靶向治疗局部晚期或转移性黑色素瘤患者:AMBER 队列 1c、1e 和 2A

Davar, Diwakar; Eroglu, Zeynep; Pérez, Casilda Llácer; Di Pace, Brian; Wang, Tianli; Yanamandra, Niranjan; Ghosh, Srimoyee; Jansen, Kathrin; Dhar, Arindam; Borgovan, Theo; Waszak, Angela; Ribas, Antoni

Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study

在程序性死亡受体1阻断耐药的黑色素瘤患者中,瘤内注射维杜托利莫德作为单药治疗或与帕博利珠单抗联合治疗:一项1b期研究的最终分析

Milhem, Mohammed M; Zakharia, Yousef; Davar, Diwakar; Buchbinder, Elizabeth I; Medina, Theresa; Daud, Adil; Ribas, Antoni; Chmielowski, Bartosz; Niu, Jiaxin; Gibney, Geoffrey T; Margolin, Kim; Olszanski, Anthony J; Mehmi, Inderjit; Sato, Takami; Shaheen, Montaser; Zhao, Luping; Kelley, Heather; Liu, Hong; Kumar, Sujatha; Bobilev, Dmitri; Krieg, Arthur M; Wooldridge, James E; Kirkwood, John M